Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1.
Microvascular networks undergo patterning changes that determine and reflect functional adaptations during tissue remodeling. Alterations in network architectures are a result of complex and integrated signaling events. To understand how two growth factor signals interact to stimulate angiogenesis and arterialization, we engineered spatially directed microvascular pattern changes in vivo by using combinations of focally delivered exogenous growth factors. We implanted microdelivery beads containing recombinant vascular endothelial growth factor-164 (VEGF(164)) and recombinant angiopoietin-1* (Ang-1*) into the dorsal subcutaneous tissue of fully anesthetized male Fischer 344 rats implanted with backpack window chambers, and we quantified vascular patterning changes by using intravital microscopy, a combination of architectural metrics, and immunohistochemistry. Focal delivery of VEGF(164) caused spatially directed increases in both the total number and the density of vessels with diameters <25 microm 7 days after microbead implantation. Increases were maintained out to 14 days but were reduced to control values by day 21. The addition of Ang-1* on day 7 maintained these increases out to day 21, induced vessel order ratios comparable to control levels, and was accompanied by increases in the length density of smooth muscle alpha-actin-positive vessels. We achieved spatial control of patterning changes in vivo by using multisignal stimulation via focal delivery of exogenous growth factor combinations and conclude that Ang-1* administered subsequent to VEGF(164) stimulation induces vascular growth while maintaining a network pattern consistent with native patterns that persist in the presence of vehicle control stimulation.
Peirce
Shayn M
SM
Dept. of Biomedical Engineering, Univ. of Virginia, Box 800759, Health System, Charlottesville, VA 22908, USA. smp6p@virginia.edu
Price
Richard J
RJ
Skalak
Thomas C
TC
D000464:Alginates; D042683:Angiopoietin-1 / Q000494:pharmacology*; D000818:Animals; D004058:Diffusion; D016503:Drug Delivery Systems; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D007457:Iodine Radioisotopes; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008863:Microspheres; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D051381:Rats; D011916:Rats, Inbred F344; D012867:Skin / Q000098:blood supply*; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology*
D000464:Alginates; D042683:Angiopoietin-1; D006603:Hexuronic Acids; D007457:Iodine Radioisotopes; D042461:Vascular Endothelial Growth Factor A; C467498:vascular endothelial growth factor A, rat; D020723:Glucuronic Acid